RT Journal Article
SR Electronic
T1 Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001701corr1
DO 10.1136/jitc-2020-001701corr1
VO 9
IS 10
YR 2021
UL http://jitc.bmj.com/content/9/10/e001701corr1.abstract